We need more evidence to guide us in the management of silent ischemia. Confirmed asymptomatic coronary artery disease is a problem for cardiologists, who lack enough evidence to guide a risk-benefit assessment that justifies revascularization. Revascularizing the outcome of a functional assessment may reduce the rates of death and infarction, or it may just be…
Diabetics’ Silent Ischemia Myth Busted
Diabetes mellitus patients generally present more diffuse coronary disease, faster lesion progression and higher risk of restenosis after PCI. The way these anatomical differences translate into in a different clinical practice, compared to non-diabetic patients, remains unclear. Prior studies comparing the frequency of angina symptoms in diabetic vs. non-diabetic patients have arrived to contradicting outcomes,…
Does PCI Improve Survival in Patients with Stable Heart Disease? COURAGE Extended Analysis
Original Title: Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. Reference: Steven P. Sedlis et al. N Engl J Med 2015;373:1937-46. Courtesy of Dr. Santiago Alonso. Centro Cardiológico Americano. Sanatorio Americano. Montevideo, Uruguay. During a median follow up of 4.6 years, with 2287 stable heart disease or silent ischemia patients,…